Takashi Honda

13.5k total citations · 1 hit paper
439 papers, 9.4k citations indexed

About

Takashi Honda is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Takashi Honda has authored 439 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Epidemiology, 120 papers in Hepatology and 98 papers in Surgery. Recurrent topics in Takashi Honda's work include Liver Disease Diagnosis and Treatment (95 papers), Hepatitis C virus research (64 papers) and Hepatitis B Virus Studies (43 papers). Takashi Honda is often cited by papers focused on Liver Disease Diagnosis and Treatment (95 papers), Hepatitis C virus research (64 papers) and Hepatitis B Virus Studies (43 papers). Takashi Honda collaborates with scholars based in Japan, United States and United Kingdom. Takashi Honda's co-authors include Masatoshi Ishigami, Yoshinori Watanabe, Yuya Yamagishi, Hidemi Goto, Kazuhiko Hayashi, Teiji Kuzuya, Yoji Ishizu, Yuji Tanno, Hisao Ogawa and Kazufumi Tsuchihashi and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Takashi Honda

412 papers receiving 9.1k citations

Hit Papers

Transient left ventricular apical ballooning without coro... 2001 2026 2009 2017 2001 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takashi Honda Japan 43 2.4k 2.2k 2.0k 1.9k 1.4k 439 9.4k
Brigitte Vollmar Germany 60 2.9k 1.2× 657 0.3× 2.5k 1.3× 4.9k 2.6× 2.1k 1.5× 530 14.3k
Tom Eirik Mollnes Norway 62 2.4k 1.0× 1.2k 0.5× 2.2k 1.1× 3.1k 1.7× 328 0.2× 500 16.1k
Bruce N. Cronstein United States 76 5.3k 2.3× 970 0.4× 1.6k 0.8× 2.1k 1.1× 415 0.3× 254 20.5k
Masahiro Ito Japan 37 1.7k 0.7× 1.0k 0.5× 1.8k 0.9× 1.4k 0.7× 578 0.4× 296 6.9k
F. Jung Germany 44 1.6k 0.7× 1.4k 0.6× 810 0.4× 2.1k 1.1× 229 0.2× 636 10.4k
Ikuro Maruyama Japan 65 3.6k 1.5× 1.8k 0.8× 2.3k 1.2× 1.6k 0.9× 185 0.1× 412 15.9k
Yasufumi Kaneda Japan 79 11.8k 5.0× 2.4k 1.1× 2.1k 1.1× 4.0k 2.1× 1.3k 0.9× 470 24.5k
Kazuo Takahashi Japan 50 2.4k 1.0× 680 0.3× 1.7k 0.9× 726 0.4× 225 0.2× 311 8.1k
Motohiro Takeya Japan 75 5.8k 2.5× 1.6k 0.7× 1.8k 0.9× 2.2k 1.2× 371 0.3× 337 18.2k
Masatoshi Fujita Japan 54 5.0k 2.1× 3.2k 1.5× 1.6k 0.8× 1.8k 1.0× 143 0.1× 368 12.2k

Countries citing papers authored by Takashi Honda

Since Specialization
Citations

This map shows the geographic impact of Takashi Honda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Honda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Honda more than expected).

Fields of papers citing papers by Takashi Honda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Honda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Honda. The network helps show where Takashi Honda may publish in the future.

Co-authorship network of co-authors of Takashi Honda

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Honda. A scholar is included among the top collaborators of Takashi Honda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Honda. Takashi Honda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishikawa, Takuya, Kazuyuki Mizuno, Takafumi Yamamoto, et al.. (2025). Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitors. Digestive and Liver Disease. 57(4). 877–884.
2.
Yamamura, Takeshi, Masanao Nakamura, Masayuki Hiramatsu, et al.. (2025). Effectiveness of self-assembling peptide in reducing bleeding after colorectal endoscopic submucosal dissection. Gastrointestinal Endoscopy. 103(4). 747–759.e2.
3.
Nakamura, Masanao, Takeshi Yamamura, Keiko Maeda, et al.. (2024). Long-Term Monitoring and Clinical Implications of Small Bowel Capsule Endoscopy in Patients with Crohn’s Disease with Small Bowel Lesions: A Retrospective Analysis. Digestion. 105(5). 380–388. 2 indexed citations
4.
Imai, Norihiro, Yuki Ohsaki, Jinglei Cheng, et al.. (2023). Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases. Scientific Reports. 13(1). 6851–6851. 8 indexed citations
5.
Ishizu, Yoji, Yukio Ando, Shinya Yokoyama, et al.. (2022). An improved method to assess skeletal muscle mass in patients with liver cirrhosis based on computed tomography images. Hepatology Research. 52(11). 937–946. 5 indexed citations
6.
Yamamoto, Kenta, Takashi Honda, Takanori Ito, et al.. (2022). Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma. Digestive Diseases. 41(1). 138–147. 7 indexed citations
7.
Fujii, Masazumi, et al.. (2020). Soluble protein tyrosine phosphatase receptor type Z (PTPRZ) in cerebrospinal fluid is a potential diagnostic marker for glioma. Neuro-Oncology Advances. 2(1). vdaa055–vdaa055. 8 indexed citations
8.
Yamamoto, Kenta, Masatoshi Ishigami, Takashi Honda, et al.. (2019). Influence of proton pump inhibitors on microbiota in chronic liver disease patients. Hepatology International. 13(2). 234–244. 35 indexed citations
9.
Kuzuya, Teiji, Masatoshi Ishigami, Takanori Ito, et al.. (2019). Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma. Hepatology Research. 50(3). 374–381. 25 indexed citations
10.
Itatani, Keiichi, et al.. (2018). Flow Energy Loss as a Predictive Parameter for Right Ventricular Deterioration Caused by Pulmonary Regurgitation After Tetralogy of Fallot Repair. Pediatric Cardiology. 39(4). 731–742. 24 indexed citations
11.
Higashi, Kouji, Yuichi Ishikawa, Toshiyuki Itoi, et al.. (2015). Efficacy and safety of tolvaptan for pediatric patients with congestive heart failure. Multicenter survey in the working group of the Japanese Society of PEdiatric Circulation and Hemodynamics (J-SPECH). International Journal of Cardiology. 205. 37–42. 21 indexed citations
12.
Hayashi, Kazuhiko, Yoshiaki Katano, Yoji Ishizu, et al.. (2014). Association of interleukin 28 B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness. Journal of Gastroenterology and Hepatology. 30(1). 178–183. 8 indexed citations
13.
Honda, Takashi, Masatoshi Ishigami, Hiroko Masuda, et al.. (2014). Effect of peginterferon alfa‐2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C. Journal of Gastroenterology and Hepatology. 30(2). 321–328. 7 indexed citations
14.
Nakahata, Yayoi, et al.. (2011). Percutaneous bilateral pulmonary artery banding using a re-expandable covered stent: preliminary animal study. 41(2). 165–169. 6 indexed citations
15.
Yamagishi, Yuya, Takashi Honda, Yuji Tanno, & Yoshinori Watanabe. (2010). Two Histone Marks Establish the Inner Centromere and Chromosome Bi-Orientation. Science. 330(6001). 239–243. 369 indexed citations
16.
Kawashima, Shigehiro A., Yuya Yamagishi, Takashi Honda, Kei‐ichiro Ishiguro, & Yoshinori Watanabe. (2009). Phosphorylation of H2A by Bub1 Prevents Chromosomal Instability Through Localizing Shugoshin. Science. 327(5962). 172–177. 376 indexed citations
17.
Yamada, Atsushi, et al.. (2008). Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice. Clinical Cancer Research. 14(24). 8161–8168. 116 indexed citations
19.
Honda, Takashi, Yoshihide Fukuda, Isao Nakano, et al.. (2003). Effects of liver failure on branched-chain α-keto acid dehydrogenase complex in rat liver and muscle: comparison between acute and chronic liver failure. Journal of Hepatology. 40(3). 439–445. 26 indexed citations
20.
Murohara, Toyoaki, Shinji Tayama, Toshifumi Tabuchi, et al.. (1996). Effects of angiotensin-converting enzyme inhibitor alacepril in patients with stable effort angina during chronic isosorbide dinitrate treatment. The American Journal of Cardiology. 77(14). 1159–1163. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026